Literature DB >> 15163761

Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis.

Corinne Barat1, Philippe Gervais, Michel J Tremblay.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication is regulated by several extracellular signals. We demonstrate that intercellular adhesion molecule 3 (ICAM-3) acts as a costimulating molecule to increase HIV-1 transcription and viral production, a process allowing productive infection of quiescent CD4+ T lymphocytes. The present work suggests an important role for ICAM-3 in HIV-1 replication.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15163761      PMCID： PMC416497          DOI： 10.1128/JVI.78.12.6692-6697.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  56 in total

1.  Induction of HIV-1 replication by allogeneic stimulation.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  Molecular basis for the loss of CD28 expression in senescent T cells.

Authors:  Abbe N Vallejo; Ewa Bryl; Klaus Klarskov; Stephen Naylor; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

3.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

Authors:  S E Tong-Starkesen; P A Luciw; B M Peterlin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.

Authors:  Joseph Kulkosky; Giuseppe Nunnari; Miguel Otero; Sandra Calarota; Geetha Dornadula; Hui Zhang; Anne Malin; Julie Sullivan; Yan Xu; Joseph DeSimone; Timothy Babinchak; John Stern; Winston Cavert; Ashley Haase; Roger J Pomerantz
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

6.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

7.  Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

Authors:  T W Chun; D Engel; S B Mizell; C W Hallahan; M Fischette; S Park; R T Davey; M Dybul; J A Kovacs; J A Metcalf; J M Mican; M M Berrey; L Corey; H C Lane; A S Fauci
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

8.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

10.  Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element.

Authors:  Michael J Giffin; James C Stroud; Darren L Bates; Konstanze D von Koenig; John Hardin; Lin Chen
Journal:  Nat Struct Biol       Date:  2003-08-31
View more
  3 in total

Review 1.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.

Authors:  Julia E Biggins; Tasha Biesinger; Monica T Yu Kimata; Reetakshi Arora; Jason T Kimata
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

3.  Retrospective Proteomic Analysis of Cellular Immune Responses and Protective Correlates of p24 Vaccination in an HIV Elite Controller Using Antibody Arrays.

Authors:  Suneth S Perera; Bin Wang; Arturo Damian; Wayne Dyer; Li Zhou; Viviane Conceicao; Nitin K Saksena
Journal:  Microarrays (Basel)       Date:  2016-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.